-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Fusion Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q1 2024.
- Fusion Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$35.9M, a 44.3% decline year-over-year.
- Fusion Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$110M, a 19.4% decline year-over-year.
- Fusion Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$99.2M, a 12.7% decline from 2022.
- Fusion Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$88M, a 7.34% decline from 2021.
- Fusion Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$82M, a 116% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)